XML 67 R53.htm IDEA: XBRL DOCUMENT v3.25.4
Impairment loss on goodwill (Tables)
12 Months Ended
Jun. 30, 2025
Impairment Loss On Goodwill  
Schedule of fair value of identifiable assets and liabilities

The fair value of identifiable assets and liabilities of Bethesda Group as at the acquisition date were:

 

 Schedule of fair value of identifiable assets and liabilities

   2025 
   S$ 
     
Purchase Consideration   10,339,950 
      
Assets and liabilities recognised as a result of the acquisition:     
Plant and equipment   613,330 
Right-of-use assets   2,906,640 
Deferred tax assets   34,700 
Inventories   388,850 
Trade and other receivables   1,344,120 
Cash and cash equivalents   217,110 
Lease liabilities   (2,906,640)
Deferred tax liabilities   

(118,510

)
Trade and other payables   (2,294,950)
Amount due to director   (193,950)
Net identifiable assets acquired   (9,300)
Add: Goodwill   10,349,250 
Purchase consideration   10,339,950 
Schedule of impairment testing carrying amount of goodwill

For the purposes of impairment testing, the carrying amount of the goodwill has been allocated to the respective clinics based on the revenue generated by each CGUs in the past 12 months as follows:

 

Schedule of impairment testing carrying amount of goodwill

Clinics 

Goodwill allocated

S$

 
Bethesda Medical Clinic (Suntec)   3,721,673 
Bethesda Medical Clinic (Grantral Mall-Macpherson)   1,812,274 
Bethesda Medical Clinic (Toa Payoh)   1,632,637 
Bethesda Medical Clinic (Beach Road)   1,185,408 
Bethesda Medical Clinic (Margaret Drive)   847,978 
Bethesda Medical Clinic (Tampines)   1,149,280 
Total   10,349,250 
Schedule of key assumptions used in the estimation of value

Key assumptions used in the estimation of value in use were as follows:

 

Schedule of key assumptions used in the estimation of value

Discount rate   5.4%
Terminal growth rate   2%
Revenue growth rate for next five years   5%